Knott David M Jr Mereo Biopharma Group PLC Transaction History
Knott David M Jr
- $283 Million
- Q1 2024
A detailed history of Knott David M Jr transactions in Mereo Biopharma Group PLC stock. As of the latest transaction made, Knott David M Jr holds 30,000 shares of MREO stock, worth $103,500. This represents 0.04% of its overall portfolio holdings.
Number of Shares
30,000Holding current value
$103,500% of portfolio
0.04%Shares
1 transactions
Others Institutions Holding MREO
# of Institutions
88Shares Held
85.6MCall Options Held
182KPut Options Held
249K-
Rubric Capital Management LP New York, NY13.6MShares$46.8 Million1.52% of portfolio
-
Adage Capital Partners Gp, L.L.C. Boston, MA9.33MShares$32.2 Million0.06% of portfolio
-
Mangrove Partners New York, NY8.75MShares$30.2 Million3.09% of portfolio
-
Rock Springs Capital Management LP Baltimore, MD8.14MShares$28.1 Million0.7% of portfolio
-
683 Capital Management, LLC New York, NY5.75MShares$19.8 Million1.62% of portfolio
About Mereo Biopharma Group plc
- Ticker MREO
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 124,986,000
- Market Cap $431M
- Description
- Mereo BioPharma Group plc, a biopharmaceutical company, develops and commercializes therapeutics for the treatment of oncology and rare diseases in the United Kingdom and internationally. Its lead product candidate, etigilimab (OMP-313M32), an antibody T-cell immunoreceptor with Ig and ITIM domains, which is in Phase 1b clinical trial for the tr...